Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
AI Revolutionizes Cybersecurity by Doing What Humans Cannot
Leaders from NSA, GAO and industry say that artificial intelligence can augment the cybersecurity workforce, but the work must be auditable and explainable.
4m read -
Elevating Cybersecurity in the Intelligence Community
The Intelligence Community is developing strategies to protect data and strengthen resiliency against emerging cyber threats.
30m watch -
Agencies Prioritize Pilots, Literacy to Overcome AI Challenges
DOL and HUD focus on change management and AI literacy to overcome adoption challenges and boost operational efficiency.
5m read -
Responsible AI Development Requires Risk Management
Officials emphasize the importance of addressing bias, data quality and civil liberties in AI implementation.
4m read
